Isis Aboriginal Trust is categorized under Commercial Medical Research in Philadelphia, PA and active since 2010.
Isis Aboriginal Trust was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Abdul-Ali Muhammad at the company’s single location by writing to 1253 South 22nd St, Philadelphia, Pennsylvania PA 19146 or by phoning (215) 688-1582. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Isis Aboriginal Trust |
| Contact Person: | Abdul-Ali Muhammad |
| Address: | 1253 South 22nd St, Philadelphia, Pennsylvania 19146 |
| Phone Number: | (215) 688-1582 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Isis Aboriginal Trust was started in 2010 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Abdul-Ali Muhammad for inquiries that concern Isis Aboriginal Trust by calling the company number (215) 688-1582, as your correspondence is most welcome. Additionally, the physical location of the single location of Isis Aboriginal Trust can be found at the coordinates 39.936308,-75.180319 as well as the street address 1253 South 22nd St in Philadelphia, Pennsylvania 19146.
For its online presence, you may visit Isis Aboriginal Trust’s website at and engage with its social media outlets through on Twitter and on Facebook.